Effect of macrophage migration inhibitory factor on inflammatory cytokines and fibrogenic gene expression in human RPE cells

巨噬细胞移动抑制因子对人RPE细胞炎症因子及纤维化基因表达的影响

阅读:11
作者:Dong Qin, Yanrong Jiang, Xuemin Jin

Abstract

Proliferative vitreoretinopathy (PVR) is a vision‑threatening disease. It is also a common complication resulting from surgery to correct rhegmatogenous retinal detachment. Proliferation and migration of retinal pigment epithelial (RPE) cells and the secretion of extracellular matrix molecules play an important role in the formation of the preretinal membrane in PVR patients. Furthermore, upregulated expression of inflammatory cytokines within the vitreous or subretinal fluid of patients experiencing vitreoretinal disorders may aggravate the inflammatory response and be involved in the development of PVR. PVR is triggered by many inflammatory cytokines and growth factors. Macrophage migration inhibitory factor (MIF), an inflammatory cytokine, is upregulated in the vitreous in PVR patients. However, there is little known concerning the connection between MIF and the expression of inflammatory cytokines, interleukin‑6 (IL‑6) and monocyte chemotactic‑1 (MCP‑1), and the fibrogenic gene, collagen I, in human RPE cells. Cell proliferation, migration, and expression of IL‑6, MCP‑1 and collagen I were assessed using an MTT assay, a Transwell assay, real‑time PCR analysis and ELISA kits. Western‑blot analysis was used to detect phosphorylation of p38 mitogen activated protein kinase (MAPK) and extracellular signal‑regulated kinase (ERK) signaling pathways. The data revealed that MIF promoted the proliferation, migration and expression of IL‑6, MCP‑1 and collagen I, and phosphorylation of p38 and ERK signaling pathways in RPE cells in vitro. These findings suggest that MIF plays a proinflammatory and profibrotic role in the development of PVR.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。